Completed NA INTERVENTIONAL 2-arm NCT06421207

Open Label Study Exploring Tissue Histopathology After Ellacor® Procedure in an Abdominoplasty Model.

Open Label Study to Explore Tissue Histopathology Following Reduction in Skin Surface Using the Ellacor® Micro-Coring™ Procedure in an Abdominoplasty Model.

Sponsor: Cytrellis Biosystems, Inc.

Conditions Histopathology Rhytides Wrinkle

Interventions ellacor® Micro-Coring procedure

Updated 3 times since 2024 Last updated: May 15, 2024 Started: Feb 22, 2023 Primary completion: Jun 19, 2023 Completion: Oct 4, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Histopathology and Rhytides, this trial is completed. The trial is conducted by Cytrellis Biosystems, Inc. and has accumulated 3 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2024 — Jul 2024 [monthly]

Completed NA

First recorded

Feb 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cytrellis Biosystems, Inc.
Dallas Plastic Surgery Institute

Data source: Cytrellis Biosystems, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dallas, United States